Our top pick for
Building a portfolio
Happiness Biotech Group Limited is a drug manufacturers-specialty & generic business based in the US. Happiness Biotech Group shares (HAPP) are listed on the NASDAQ and all prices are listed in US Dollars. Happiness Biotech Group employs 151 staff and has a trailing 12-month revenue of around USD$55.6 million.
|52-week range||USD$1.63 - USD$4.0546|
|50-day moving average||USD$2.1177|
|200-day moving average||USD$1.9356|
|Wall St. target price||USD$10.5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.797|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Happiness Biotech Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Happiness Biotech Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Happiness Biotech Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Happiness Biotech Group shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Happiness Biotech Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$10 million.
The EBITDA is a measure of a Happiness Biotech Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$55.6 million|
|Operating margin TTM||16.67%|
|Gross profit TTM||USD$30.4 million|
|Return on assets TTM||7.03%|
|Return on equity TTM||9.68%|
|Market capitalisation||USD$53.9 million|
TTM: trailing 12 months
There are currently 80,161 Happiness Biotech Group shares held short by investors – that's known as Happiness Biotech Group's "short interest". This figure is 54.9% down from 177,799 last month.
There are a few different ways that this level of interest in shorting Happiness Biotech Group shares can be evaluated.
Happiness Biotech Group's "short interest ratio" (SIR) is the quantity of Happiness Biotech Group shares currently shorted divided by the average quantity of Happiness Biotech Group shares traded daily (recently around 890677.77777778). Happiness Biotech Group's SIR currently stands at 0.09. In other words for every 100,000 Happiness Biotech Group shares traded daily on the market, roughly 90 shares are currently held short.
However Happiness Biotech Group's short interest can also be evaluated against the total number of Happiness Biotech Group shares, or, against the total number of tradable Happiness Biotech Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Happiness Biotech Group's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Happiness Biotech Group shares in existence, roughly 0 shares are currently held short) or 0.0082% of the tradable shares (for every 100,000 tradable Happiness Biotech Group shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Happiness Biotech Group.
Find out more about how you can short Happiness Biotech Group stock.
We're not expecting Happiness Biotech Group to pay a dividend over the next 12 months.
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powder, cordyceps mycelia, ejiao solution, American ginseng, and other products. It also offers a range of ganoderma lucidum products, such as essence oil, cleansing milk, shampoo, shower gel, and nourishing cream products under the Cai Zhi Ning brand, as well as edible fungi. In addition, the company provides disinfectants, non-medical face masks, and COVID-19 anti-body testing kits. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. Happiness Biotech Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China. .
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.